Sort   by:  
 Page size 
UnknownEarly Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Not available
S-EPMC4879714 | biostudies-literature
UnknownEvent-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.
Not available
S-EPMC3965261 | biostudies-literature
UnknownDisease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Not available
S-EPMC5006260 | biostudies-literature
UnknownGenome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
Not available
S-EPMC4879713 | biostudies-literature
UnknownTreatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
Not available
S-EPMC11909426 | biostudies-literature
UnknownHair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
Not available
S-EPMC2085367 | biostudies-literature
UnknownGenetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Not available
S-EPMC1986787 | biostudies-literature
UnknownEvaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL.
Not available
S-EPMC11375257 | biostudies-literature
Sort   by:  
 Page size